WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsGoodrx Holdings Inc (GDRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 1520% more annual revenue ($12.91B vs $796.85M). GDRX leads profitability with a 3.8% profit margin vs 1.5%. GDRX trades at a lower P/E of 22.6x. BTSG earns a higher WallStSmart Score of 54/100 (C-).

BTSG

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 3.0Quality: 7.5
Piotroski: 5/9Altman Z: 2.62

GDRX

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 5.5Value: 5.7Quality: 7.0
Piotroski: 5/9Altman Z: 0.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BTSGSignificantly Overvalued (-78.4%)

Margin of Safety

-78.4%

Fair Value

$22.46

Current Price

$44.82

$22.36 premium

UndervaluedFair: $22.46Overvalued
GDRXSignificantly Overvalued (-265.6%)

Margin of Safety

-265.6%

Fair Value

$0.61

Current Price

$2.06

$1.45 premium

UndervaluedFair: $0.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

GDRX1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Areas to Watch

BTSG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Operating MarginProfitability
3.0%3/10

Operating margin of 3.0%

GDRX4 concerns · Avg: 2.8/10
Market CapQuality
$695.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

Profit MarginProfitability
3.8%3/10

3.8% margin — thin

Revenue GrowthGrowth
-1.9%2/10

Revenue declined 1.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bull Case : GDRX

The strongest argument for GDRX centers on Price/Book.

Bear Case : BTSG

The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Bear Case : GDRX

The primary concerns for GDRX are Market Cap, Return on Equity, Profit Margin. Thin 3.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

BTSG profiles as a growth stock while GDRX is a value play — different risk/reward profiles.

BTSG carries more volatility with a beta of 2.33 — expect wider price swings.

BTSG is growing revenue faster at 29.3% — sustainability is the question.

BTSG generates stronger free cash flow (174M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (54/100 vs 41/100) and 29.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.

Visit Website →

Goodrx Holdings Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Visit Website →

Want to dig deeper into these stocks?